Signature Eyewear, Inc.
Get $10 bonus on your first $100 deposit for SEYE
Get $10 bonus on your first $100 deposit for SEYE
Signature Eyewear, Inc. (SEYE) Stock Competitors & Peer Comparison
See (SEYE) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| SEYE | $0.00 | +0.00% | 1.2K | N/A | N/A | N/A |
| SRTOY | $20.41 | +2.15% | 201.7B | 64.80 | $0.32 | +0.21% |
| MECNY | $88.63 | +0.00% | 107.5B | N/A | N/A | N/A |
| ESLOY | $116.43 | +0.00% | 106.8B | 40.89 | $2.84 | +1.94% |
| ESLOF | $233.88 | +1.46% | 106.5B | 39.44 | $5.83 | +1.96% |
| SOAGY | $53.47 | +6.81% | 74.8B | 98.50 | $0.52 | +0.18% |
| HOCPY | $185.99 | -0.11% | 62.8B | 48.66 | $3.83 | +0.68% |
| HOCPF | $179.27 | +8.65% | 60.4B | 46.81 | $3.83 | +0.94% |
| RSMDF | $24.89 | +26.60% | 36.3B | 24.64 | $1.01 | +1.02% |
| TRUMY | $13.58 | +0.89% | 20B | 24.20 | $0.56 | +1.32% |
Stock Comparison
SEYE vs SRTOY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SRTOY has a market cap of 201.7B. Regarding current trading prices, SEYE is priced at $0.00, while SRTOY trades at $20.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SRTOY's P/E ratio is 64.80. In terms of profitability, SEYE's ROE is N/A, compared to SRTOY's ROE of +0.06%. Regarding short-term risk, SEYE is less volatile compared to SRTOY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SRTOY's competition here
SEYE vs MECNY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, MECNY has a market cap of 107.5B. Regarding current trading prices, SEYE is priced at $0.00, while MECNY trades at $88.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas MECNY's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to MECNY's ROE of +0.02%. Regarding short-term risk, SEYE and MECNY have similar daily volatility (0.00).Check MECNY's competition here
SEYE vs ESLOY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ESLOY has a market cap of 106.8B. Regarding current trading prices, SEYE is priced at $0.00, while ESLOY trades at $116.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ESLOY's P/E ratio is 40.89. In terms of profitability, SEYE's ROE is N/A, compared to ESLOY's ROE of +0.06%. Regarding short-term risk, SEYE is less volatile compared to ESLOY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check ESLOY's competition here
SEYE vs ESLOF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ESLOF has a market cap of 106.5B. Regarding current trading prices, SEYE is priced at $0.00, while ESLOF trades at $233.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ESLOF's P/E ratio is 39.44. In terms of profitability, SEYE's ROE is N/A, compared to ESLOF's ROE of +0.06%. Regarding short-term risk, SEYE and ESLOF have similar daily volatility (0.00).Check ESLOF's competition here
SEYE vs SOAGY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SOAGY has a market cap of 74.8B. Regarding current trading prices, SEYE is priced at $0.00, while SOAGY trades at $53.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SOAGY's P/E ratio is 98.50. In terms of profitability, SEYE's ROE is N/A, compared to SOAGY's ROE of +0.06%. Regarding short-term risk, SEYE and SOAGY have similar daily volatility (0.00).Check SOAGY's competition here
SEYE vs HOCPY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, HOCPY has a market cap of 62.8B. Regarding current trading prices, SEYE is priced at $0.00, while HOCPY trades at $185.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas HOCPY's P/E ratio is 48.66. In terms of profitability, SEYE's ROE is N/A, compared to HOCPY's ROE of +0.25%. Regarding short-term risk, SEYE is less volatile compared to HOCPY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check HOCPY's competition here
SEYE vs HOCPF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, HOCPF has a market cap of 60.4B. Regarding current trading prices, SEYE is priced at $0.00, while HOCPF trades at $179.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas HOCPF's P/E ratio is 46.81. In terms of profitability, SEYE's ROE is N/A, compared to HOCPF's ROE of +0.25%. Regarding short-term risk, SEYE and HOCPF have similar daily volatility (0.00).Check HOCPF's competition here
SEYE vs RSMDF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, RSMDF has a market cap of 36.3B. Regarding current trading prices, SEYE is priced at $0.00, while RSMDF trades at $24.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas RSMDF's P/E ratio is 24.64. In terms of profitability, SEYE's ROE is N/A, compared to RSMDF's ROE of +0.25%. Regarding short-term risk, SEYE is less volatile compared to RSMDF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check RSMDF's competition here
SEYE vs TRUMY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TRUMY has a market cap of 20B. Regarding current trading prices, SEYE is priced at $0.00, while TRUMY trades at $13.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TRUMY's P/E ratio is 24.20. In terms of profitability, SEYE's ROE is N/A, compared to TRUMY's ROE of +0.09%. Regarding short-term risk, SEYE is less volatile compared to TRUMY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TRUMY's competition here
SEYE vs SDMHF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SDMHF has a market cap of 19.9B. Regarding current trading prices, SEYE is priced at $0.00, while SDMHF trades at $205.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SDMHF's P/E ratio is 65.08. In terms of profitability, SEYE's ROE is N/A, compared to SDMHF's ROE of +0.07%. Regarding short-term risk, SEYE is less volatile compared to SDMHF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SDMHF's competition here
SEYE vs TRUMF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TRUMF has a market cap of 18.3B. Regarding current trading prices, SEYE is priced at $0.00, while TRUMF trades at $12.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TRUMF's P/E ratio is 22.55. In terms of profitability, SEYE's ROE is N/A, compared to TRUMF's ROE of +0.09%. Regarding short-term risk, SEYE is less volatile compared to TRUMF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TRUMF's competition here
SEYE vs SAUHY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SAUHY has a market cap of 17.3B. Regarding current trading prices, SEYE is priced at $0.00, while SAUHY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SAUHY's P/E ratio is 38.71. In terms of profitability, SEYE's ROE is N/A, compared to SAUHY's ROE of +0.17%. Regarding short-term risk, SEYE and SAUHY have similar daily volatility (0.00).Check SAUHY's competition here
SEYE vs SUVPF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SUVPF has a market cap of 16.9B. Regarding current trading prices, SEYE is priced at $0.00, while SUVPF trades at $244.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SUVPF's P/E ratio is 94.40. In terms of profitability, SEYE's ROE is N/A, compared to SUVPF's ROE of +0.06%. Regarding short-term risk, SEYE is less volatile compared to SUVPF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SUVPF's competition here
SEYE vs SAUHF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SAUHF has a market cap of 16.7B. Regarding current trading prices, SEYE is priced at $0.00, while SAUHF trades at $111.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SAUHF's P/E ratio is 37.48. In terms of profitability, SEYE's ROE is N/A, compared to SAUHF's ROE of +0.17%. Regarding short-term risk, SEYE and SAUHF have similar daily volatility (0.00).Check SAUHF's competition here
SEYE vs SARTF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SARTF has a market cap of 15.6B. Regarding current trading prices, SEYE is priced at $0.00, while SARTF trades at $226.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SARTF's P/E ratio is 87.72. In terms of profitability, SEYE's ROE is N/A, compared to SARTF's ROE of +0.06%. Regarding short-term risk, SEYE is less volatile compared to SARTF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SARTF's competition here
SEYE vs CLPBY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CLPBY has a market cap of 15.1B. Regarding current trading prices, SEYE is priced at $0.00, while CLPBY trades at $6.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CLPBY's P/E ratio is 23.95. In terms of profitability, SEYE's ROE is N/A, compared to CLPBY's ROE of +0.25%. Regarding short-term risk, SEYE and CLPBY have similar daily volatility (0.00).Check CLPBY's competition here
SEYE vs SSSGY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SSSGY has a market cap of 13.6B. Regarding current trading prices, SEYE is priced at $0.00, while SSSGY trades at $39.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SSSGY's P/E ratio is 75.87. In terms of profitability, SEYE's ROE is N/A, compared to SSSGY's ROE of +0.06%. Regarding short-term risk, SEYE is less volatile compared to SSSGY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SSSGY's competition here
SEYE vs CLPBF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CLPBF has a market cap of 13.5B. Regarding current trading prices, SEYE is priced at $0.00, while CLPBF trades at $65.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CLPBF's P/E ratio is 23.66. In terms of profitability, SEYE's ROE is N/A, compared to CLPBF's ROE of +0.25%. Regarding short-term risk, SEYE is less volatile compared to CLPBF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check CLPBF's competition here
SEYE vs FSPKF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, FSPKF has a market cap of 13.5B. Regarding current trading prices, SEYE is priced at $0.00, while FSPKF trades at $23.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas FSPKF's P/E ratio is 52.32. In terms of profitability, SEYE's ROE is N/A, compared to FSPKF's ROE of +0.30%. Regarding short-term risk, SEYE and FSPKF have similar daily volatility (0.00).Check FSPKF's competition here
SEYE vs OCPNF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, OCPNF has a market cap of 10.5B. Regarding current trading prices, SEYE is priced at $0.00, while OCPNF trades at $9.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas OCPNF's P/E ratio is 17.59. In terms of profitability, SEYE's ROE is N/A, compared to OCPNF's ROE of +0.11%. Regarding short-term risk, SEYE is less volatile compared to OCPNF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check OCPNF's competition here
SEYE vs CNVVY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CNVVY has a market cap of 6.1B. Regarding current trading prices, SEYE is priced at $0.00, while CNVVY trades at $12.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CNVVY's P/E ratio is 36.68. In terms of profitability, SEYE's ROE is N/A, compared to CNVVY's ROE of +0.10%. Regarding short-term risk, SEYE is less volatile compared to CNVVY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check CNVVY's competition here
SEYE vs CNVVF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CNVVF has a market cap of 5.7B. Regarding current trading prices, SEYE is priced at $0.00, while CNVVF trades at $2.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CNVVF's P/E ratio is 32.33. In terms of profitability, SEYE's ROE is N/A, compared to CNVVF's ROE of +0.11%. Regarding short-term risk, SEYE is less volatile compared to CNVVF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check CNVVF's competition here
SEYE vs SSMXY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SSMXY has a market cap of 5.5B. Regarding current trading prices, SEYE is priced at $0.00, while SSMXY trades at $8.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SSMXY's P/E ratio is 18.64. In terms of profitability, SEYE's ROE is N/A, compared to SSMXY's ROE of +0.09%. Regarding short-term risk, SEYE and SSMXY have similar daily volatility (0.00).Check SSMXY's competition here
SEYE vs AHICF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, AHICF has a market cap of 5.4B. Regarding current trading prices, SEYE is priced at $0.00, while AHICF trades at $20.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas AHICF's P/E ratio is 48.50. In terms of profitability, SEYE's ROE is N/A, compared to AHICF's ROE of +0.12%. Regarding short-term risk, SEYE is less volatile compared to AHICF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check AHICF's competition here
SEYE vs SSMXF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SSMXF has a market cap of 5.3B. Regarding current trading prices, SEYE is priced at $0.00, while SSMXF trades at $8.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SSMXF's P/E ratio is 17.94. In terms of profitability, SEYE's ROE is N/A, compared to SSMXF's ROE of +0.09%. Regarding short-term risk, SEYE is less volatile compared to SSMXF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SSMXF's competition here
SEYE vs ADDLF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ADDLF has a market cap of 4.9B. Regarding current trading prices, SEYE is priced at $0.00, while ADDLF trades at $42.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ADDLF's P/E ratio is 61.76. In terms of profitability, SEYE's ROE is N/A, compared to ADDLF's ROE of +0.11%. Regarding short-term risk, SEYE is less volatile compared to ADDLF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check ADDLF's competition here
SEYE vs YPHDF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, YPHDF has a market cap of 4.8B. Regarding current trading prices, SEYE is priced at $0.00, while YPHDF trades at $354.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas YPHDF's P/E ratio is 19.76. In terms of profitability, SEYE's ROE is N/A, compared to YPHDF's ROE of +0.27%. Regarding short-term risk, SEYE is less volatile compared to YPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check YPHDF's competition here
SEYE vs FLMNF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, FLMNF has a market cap of 4.3B. Regarding current trading prices, SEYE is priced at $0.00, while FLMNF trades at $50.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas FLMNF's P/E ratio is 20.06. In terms of profitability, SEYE's ROE is N/A, compared to FLMNF's ROE of +0.20%. Regarding short-term risk, SEYE is less volatile compared to FLMNF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check FLMNF's competition here
SEYE vs FLMNY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, FLMNY has a market cap of 4.2B. Regarding current trading prices, SEYE is priced at $0.00, while FLMNY trades at $9.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas FLMNY's P/E ratio is 19.87. In terms of profitability, SEYE's ROE is N/A, compared to FLMNY's ROE of +0.20%. Regarding short-term risk, SEYE is less volatile compared to FLMNY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check FLMNY's competition here
SEYE vs ANSLF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ANSLF has a market cap of 3.3B. Regarding current trading prices, SEYE is priced at $0.00, while ANSLF trades at $22.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ANSLF's P/E ratio is 32.49. In terms of profitability, SEYE's ROE is N/A, compared to ANSLF's ROE of +0.07%. Regarding short-term risk, SEYE and ANSLF have similar daily volatility (0.00).Check ANSLF's competition here
SEYE vs ANSLY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ANSLY has a market cap of 3B. Regarding current trading prices, SEYE is priced at $0.00, while ANSLY trades at $83.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ANSLY's P/E ratio is 22.45. In terms of profitability, SEYE's ROE is N/A, compared to ANSLY's ROE of +0.07%. Regarding short-term risk, SEYE is less volatile compared to ANSLY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check ANSLY's competition here
SEYE vs CZMWY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CZMWY has a market cap of 2.7B. Regarding current trading prices, SEYE is priced at $0.00, while CZMWY trades at $31.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CZMWY's P/E ratio is 16.44. In terms of profitability, SEYE's ROE is N/A, compared to CZMWY's ROE of +0.06%. Regarding short-term risk, SEYE is less volatile compared to CZMWY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check CZMWY's competition here
SEYE vs CZMWF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CZMWF has a market cap of 2.7B. Regarding current trading prices, SEYE is priced at $0.00, while CZMWF trades at $30.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CZMWF's P/E ratio is 16.42. In terms of profitability, SEYE's ROE is N/A, compared to CZMWF's ROE of +0.07%. Regarding short-term risk, SEYE is less volatile compared to CZMWF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check CZMWF's competition here
SEYE vs SHWGY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SHWGY has a market cap of 2.5B. Regarding current trading prices, SEYE is priced at $0.00, while SHWGY trades at $2.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SHWGY's P/E ratio is 10.95. In terms of profitability, SEYE's ROE is N/A, compared to SHWGY's ROE of +0.07%. Regarding short-term risk, SEYE is less volatile compared to SHWGY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SHWGY's competition here
SEYE vs TCGGY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TCGGY has a market cap of 2.3B. Regarding current trading prices, SEYE is priced at $0.00, while TCGGY trades at $36.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TCGGY's P/E ratio is 27.27. In terms of profitability, SEYE's ROE is N/A, compared to TCGGY's ROE of -0.09%. Regarding short-term risk, SEYE is less volatile compared to TCGGY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TCGGY's competition here
SEYE vs EKTAF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, EKTAF has a market cap of 2.3B. Regarding current trading prices, SEYE is priced at $0.00, while EKTAF trades at $6.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas EKTAF's P/E ratio is -620.00. In terms of profitability, SEYE's ROE is N/A, compared to EKTAF's ROE of -0.00%. Regarding short-term risk, SEYE and EKTAF have similar daily volatility (0.00).Check EKTAF's competition here
SEYE vs EKTAY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, EKTAY has a market cap of 2.3B. Regarding current trading prices, SEYE is priced at $0.00, while EKTAY trades at $5.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas EKTAY's P/E ratio is -590.80. In terms of profitability, SEYE's ROE is N/A, compared to EKTAY's ROE of -0.00%. Regarding short-term risk, SEYE is less volatile compared to EKTAY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check EKTAY's competition here
SEYE vs SHWGF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SHWGF has a market cap of 2B. Regarding current trading prices, SEYE is priced at $0.00, while SHWGF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SHWGF's P/E ratio is 9.00. In terms of profitability, SEYE's ROE is N/A, compared to SHWGF's ROE of +0.07%. Regarding short-term risk, SEYE is less volatile compared to SHWGF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SHWGF's competition here
SEYE vs TCHBF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TCHBF has a market cap of 2B. Regarding current trading prices, SEYE is priced at $0.00, while TCHBF trades at $156.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TCHBF's P/E ratio is -14.26. In terms of profitability, SEYE's ROE is N/A, compared to TCHBF's ROE of -0.09%. Regarding short-term risk, SEYE and TCHBF have similar daily volatility (0.00).Check TCHBF's competition here
SEYE vs BOEUF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, BOEUF has a market cap of 1.6B. Regarding current trading prices, SEYE is priced at $0.00, while BOEUF trades at $24.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas BOEUF's P/E ratio is 108.52. In terms of profitability, SEYE's ROE is N/A, compared to BOEUF's ROE of +0.18%. Regarding short-term risk, SEYE is less volatile compared to BOEUF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check BOEUF's competition here
SEYE vs NPRRF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, NPRRF has a market cap of 1.6B. Regarding current trading prices, SEYE is priced at $0.00, while NPRRF trades at $9.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas NPRRF's P/E ratio is 26.92. In terms of profitability, SEYE's ROE is N/A, compared to NPRRF's ROE of N/A. Regarding short-term risk, SEYE is less volatile compared to NPRRF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check NPRRF's competition here
SEYE vs TGLVY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TGLVY has a market cap of 1.6B. Regarding current trading prices, SEYE is priced at $0.00, while TGLVY trades at $0.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TGLVY's P/E ratio is 39.55. In terms of profitability, SEYE's ROE is N/A, compared to TGLVY's ROE of +0.03%. Regarding short-term risk, SEYE is less volatile compared to TGLVY. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TGLVY's competition here
SEYE vs SAFLY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SAFLY has a market cap of 1.3B. Regarding current trading prices, SEYE is priced at $0.00, while SAFLY trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SAFLY's P/E ratio is 16.22. In terms of profitability, SEYE's ROE is N/A, compared to SAFLY's ROE of +0.12%. Regarding short-term risk, SEYE and SAFLY have similar daily volatility (0.00).Check SAFLY's competition here
SEYE vs BITGF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, BITGF has a market cap of 1.2B. Regarding current trading prices, SEYE is priced at $0.00, while BITGF trades at $15.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas BITGF's P/E ratio is 45.50. In terms of profitability, SEYE's ROE is N/A, compared to BITGF's ROE of +0.04%. Regarding short-term risk, SEYE is less volatile compared to BITGF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check BITGF's competition here
SEYE vs PBHDF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, PBHDF has a market cap of 1.2B. Regarding current trading prices, SEYE is priced at $0.00, while PBHDF trades at $19.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas PBHDF's P/E ratio is 12.74. In terms of profitability, SEYE's ROE is N/A, compared to PBHDF's ROE of +0.07%. Regarding short-term risk, SEYE and PBHDF have similar daily volatility (0.00).Check PBHDF's competition here
SEYE vs TDVXF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TDVXF has a market cap of 1B. Regarding current trading prices, SEYE is priced at $0.00, while TDVXF trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TDVXF's P/E ratio is 61.25. In terms of profitability, SEYE's ROE is N/A, compared to TDVXF's ROE of +0.32%. Regarding short-term risk, SEYE is less volatile compared to TDVXF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TDVXF's competition here
SEYE vs SAFLF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SAFLF has a market cap of 906.6M. Regarding current trading prices, SEYE is priced at $0.00, while SAFLF trades at $2.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SAFLF's P/E ratio is 16.50. In terms of profitability, SEYE's ROE is N/A, compared to SAFLF's ROE of +0.12%. Regarding short-term risk, SEYE and SAFLF have similar daily volatility (0.00).Check SAFLF's competition here
SEYE vs NNCSF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, NNCSF has a market cap of 849.5M. Regarding current trading prices, SEYE is priced at $0.00, while NNCSF trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas NNCSF's P/E ratio is 56.00. In terms of profitability, SEYE's ROE is N/A, compared to NNCSF's ROE of +0.10%. Regarding short-term risk, SEYE and NNCSF have similar daily volatility (0.00).Check NNCSF's competition here
SEYE vs KSRBF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, KSRBF has a market cap of 841.7M. Regarding current trading prices, SEYE is priced at $0.00, while KSRBF trades at $0.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas KSRBF's P/E ratio is 33.29. In terms of profitability, SEYE's ROE is N/A, compared to KSRBF's ROE of +0.04%. Regarding short-term risk, SEYE and KSRBF have similar daily volatility (0.00).Check KSRBF's competition here
SEYE vs HGYMF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, HGYMF has a market cap of 754.4M. Regarding current trading prices, SEYE is priced at $0.00, while HGYMF trades at $34.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas HGYMF's P/E ratio is 184.16. In terms of profitability, SEYE's ROE is N/A, compared to HGYMF's ROE of +0.00%. Regarding short-term risk, SEYE is less volatile compared to HGYMF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check HGYMF's competition here
SEYE vs GRRMF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, GRRMF has a market cap of 713.3M. Regarding current trading prices, SEYE is priced at $0.00, while GRRMF trades at $20.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas GRRMF's P/E ratio is 26.14. In terms of profitability, SEYE's ROE is N/A, compared to GRRMF's ROE of +0.02%. Regarding short-term risk, SEYE is less volatile compared to GRRMF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check GRRMF's competition here
SEYE vs JNDOF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, JNDOF has a market cap of 531M. Regarding current trading prices, SEYE is priced at $0.00, while JNDOF trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas JNDOF's P/E ratio is 47.40. In terms of profitability, SEYE's ROE is N/A, compared to JNDOF's ROE of +0.29%. Regarding short-term risk, SEYE and JNDOF have similar daily volatility (0.00).Check JNDOF's competition here
SEYE vs SPMXF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SPMXF has a market cap of 458.6M. Regarding current trading prices, SEYE is priced at $0.00, while SPMXF trades at $0.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SPMXF's P/E ratio is -15.00. In terms of profitability, SEYE's ROE is N/A, compared to SPMXF's ROE of -0.07%. Regarding short-term risk, SEYE is less volatile compared to SPMXF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check SPMXF's competition here
SEYE vs CLHLF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CLHLF has a market cap of 365.5M. Regarding current trading prices, SEYE is priced at $0.00, while CLHLF trades at $61.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CLHLF's P/E ratio is 27.93. In terms of profitability, SEYE's ROE is N/A, compared to CLHLF's ROE of +0.16%. Regarding short-term risk, SEYE and CLHLF have similar daily volatility (0.00).Check CLHLF's competition here
SEYE vs GUERF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, GUERF has a market cap of 281M. Regarding current trading prices, SEYE is priced at $0.00, while GUERF trades at $22.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas GUERF's P/E ratio is 8.19. In terms of profitability, SEYE's ROE is N/A, compared to GUERF's ROE of +0.04%. Regarding short-term risk, SEYE and GUERF have similar daily volatility (0.00).Check GUERF's competition here
SEYE vs TSNLF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TSNLF has a market cap of 249.2M. Regarding current trading prices, SEYE is priced at $0.00, while TSNLF trades at $5.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TSNLF's P/E ratio is 24.76. In terms of profitability, SEYE's ROE is N/A, compared to TSNLF's ROE of +0.24%. Regarding short-term risk, SEYE and TSNLF have similar daily volatility (0.00).Check TSNLF's competition here
SEYE vs OPSSF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, OPSSF has a market cap of 247.4M. Regarding current trading prices, SEYE is priced at $0.00, while OPSSF trades at $2.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas OPSSF's P/E ratio is -26.74. In terms of profitability, SEYE's ROE is N/A, compared to OPSSF's ROE of -0.36%. Regarding short-term risk, SEYE is less volatile compared to OPSSF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check OPSSF's competition here
SEYE vs EEOIF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, EEOIF has a market cap of 63.4M. Regarding current trading prices, SEYE is priced at $0.00, while EEOIF trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas EEOIF's P/E ratio is -2.42. In terms of profitability, SEYE's ROE is N/A, compared to EEOIF's ROE of N/A. Regarding short-term risk, SEYE and EEOIF have similar daily volatility (0.00).Check EEOIF's competition here
SEYE vs OTCFF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, OTCFF has a market cap of 21.2M. Regarding current trading prices, SEYE is priced at $0.00, while OTCFF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas OTCFF's P/E ratio is -13.22. In terms of profitability, SEYE's ROE is N/A, compared to OTCFF's ROE of +1.24%. Regarding short-term risk, SEYE is less volatile compared to OTCFF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check OTCFF's competition here
SEYE vs UEEC Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, UEEC has a market cap of 14.3M. Regarding current trading prices, SEYE is priced at $0.00, while UEEC trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas UEEC's P/E ratio is -2.76. In terms of profitability, SEYE's ROE is N/A, compared to UEEC's ROE of +1.00%. Regarding short-term risk, SEYE is less volatile compared to UEEC. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check UEEC's competition here
SEYE vs BLMHF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, BLMHF has a market cap of 5.2M. Regarding current trading prices, SEYE is priced at $0.00, while BLMHF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas BLMHF's P/E ratio is 1.56. In terms of profitability, SEYE's ROE is N/A, compared to BLMHF's ROE of N/A. Regarding short-term risk, SEYE and BLMHF have similar daily volatility (0.00).Check BLMHF's competition here
SEYE vs PXMVF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, PXMVF has a market cap of 4.6M. Regarding current trading prices, SEYE is priced at $0.00, while PXMVF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas PXMVF's P/E ratio is -0.17. In terms of profitability, SEYE's ROE is N/A, compared to PXMVF's ROE of -6.46%. Regarding short-term risk, SEYE is less volatile compared to PXMVF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check PXMVF's competition here
SEYE vs CBSC Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CBSC has a market cap of 4.5M. Regarding current trading prices, SEYE is priced at $0.00, while CBSC trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CBSC's P/E ratio is -4.00. In terms of profitability, SEYE's ROE is N/A, compared to CBSC's ROE of +0.58%. Regarding short-term risk, SEYE is less volatile compared to CBSC. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check CBSC's competition here
SEYE vs MCDA Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, MCDA has a market cap of 4.2M. Regarding current trading prices, SEYE is priced at $0.00, while MCDA trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas MCDA's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to MCDA's ROE of N/A. Regarding short-term risk, SEYE and MCDA have similar daily volatility (0.00).Check MCDA's competition here
SEYE vs GVDI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, GVDI has a market cap of 4.2M. Regarding current trading prices, SEYE is priced at $0.00, while GVDI trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas GVDI's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to GVDI's ROE of +0.00%. Regarding short-term risk, SEYE and GVDI have similar daily volatility (0.00).Check GVDI's competition here
SEYE vs RSCF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, RSCF has a market cap of 3.8M. Regarding current trading prices, SEYE is priced at $0.00, while RSCF trades at $0.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas RSCF's P/E ratio is -4.42. In terms of profitability, SEYE's ROE is N/A, compared to RSCF's ROE of +0.10%. Regarding short-term risk, SEYE and RSCF have similar daily volatility (0.00).Check RSCF's competition here
SEYE vs NSTGQ Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, NSTGQ has a market cap of 3.3M. Regarding current trading prices, SEYE is priced at $0.00, while NSTGQ trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas NSTGQ's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to NSTGQ's ROE of N/A. Regarding short-term risk, SEYE is less volatile compared to NSTGQ. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check NSTGQ's competition here
SEYE vs TUTH Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TUTH has a market cap of 2.4M. Regarding current trading prices, SEYE is priced at $0.00, while TUTH trades at $0.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TUTH's P/E ratio is -0.95. In terms of profitability, SEYE's ROE is N/A, compared to TUTH's ROE of +0.27%. Regarding short-term risk, SEYE is less volatile compared to TUTH. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TUTH's competition here
SEYE vs ECIA Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ECIA has a market cap of 1.6M. Regarding current trading prices, SEYE is priced at $0.00, while ECIA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ECIA's P/E ratio is -4.33. In terms of profitability, SEYE's ROE is N/A, compared to ECIA's ROE of -0.22%. Regarding short-term risk, SEYE and ECIA have similar daily volatility (0.00).Check ECIA's competition here
SEYE vs YBGJ Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, YBGJ has a market cap of 1.1M. Regarding current trading prices, SEYE is priced at $0.00, while YBGJ trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas YBGJ's P/E ratio is -0.95. In terms of profitability, SEYE's ROE is N/A, compared to YBGJ's ROE of +0.38%. Regarding short-term risk, SEYE and YBGJ have similar daily volatility (0.00).Check YBGJ's competition here
SEYE vs OJSY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, OJSY has a market cap of 454.3K. Regarding current trading prices, SEYE is priced at $0.00, while OJSY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas OJSY's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to OJSY's ROE of N/A. Regarding short-term risk, SEYE and OJSY have similar daily volatility (0.00).Check OJSY's competition here
SEYE vs PDMI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, PDMI has a market cap of 324.9K. Regarding current trading prices, SEYE is priced at $0.00, while PDMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas PDMI's P/E ratio is -0.01. In terms of profitability, SEYE's ROE is N/A, compared to PDMI's ROE of +0.19%. Regarding short-term risk, SEYE and PDMI have similar daily volatility (0.00).Check PDMI's competition here
SEYE vs WHSI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, WHSI has a market cap of 182.7K. Regarding current trading prices, SEYE is priced at $0.00, while WHSI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas WHSI's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to WHSI's ROE of +0.84%. Regarding short-term risk, SEYE and WHSI have similar daily volatility (0.00).Check WHSI's competition here
SEYE vs BLFE Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, BLFE has a market cap of 156.7K. Regarding current trading prices, SEYE is priced at $0.00, while BLFE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas BLFE's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to BLFE's ROE of +3.67%. Regarding short-term risk, SEYE and BLFE have similar daily volatility (0.00).Check BLFE's competition here
SEYE vs CEOS Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, CEOS has a market cap of 127.8K. Regarding current trading prices, SEYE is priced at $0.00, while CEOS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas CEOS's P/E ratio is -0.01. In terms of profitability, SEYE's ROE is N/A, compared to CEOS's ROE of +0.40%. Regarding short-term risk, SEYE and CEOS have similar daily volatility (0.00).Check CEOS's competition here
SEYE vs QTXB Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, QTXB has a market cap of 118K. Regarding current trading prices, SEYE is priced at $0.00, while QTXB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas QTXB's P/E ratio is -0.05. In terms of profitability, SEYE's ROE is N/A, compared to QTXB's ROE of +0.19%. Regarding short-term risk, SEYE is less volatile compared to QTXB. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check QTXB's competition here
SEYE vs IMTH Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, IMTH has a market cap of 89.8K. Regarding current trading prices, SEYE is priced at $0.00, while IMTH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas IMTH's P/E ratio is -0.03. In terms of profitability, SEYE's ROE is N/A, compared to IMTH's ROE of -0.60%. Regarding short-term risk, SEYE is less volatile compared to IMTH. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check IMTH's competition here
SEYE vs LANZ Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, LANZ has a market cap of 74.5K. Regarding current trading prices, SEYE is priced at $0.00, while LANZ trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas LANZ's P/E ratio is 2.70. In terms of profitability, SEYE's ROE is N/A, compared to LANZ's ROE of +0.01%. Regarding short-term risk, SEYE is less volatile compared to LANZ. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check LANZ's competition here
SEYE vs GMVDF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, GMVDF has a market cap of 26K. Regarding current trading prices, SEYE is priced at $0.00, while GMVDF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas GMVDF's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to GMVDF's ROE of +3.68%. Regarding short-term risk, SEYE and GMVDF have similar daily volatility (0.00).Check GMVDF's competition here
SEYE vs REMI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, REMI has a market cap of 14K. Regarding current trading prices, SEYE is priced at $0.00, while REMI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas REMI's P/E ratio is -0.07. In terms of profitability, SEYE's ROE is N/A, compared to REMI's ROE of -0.11%. Regarding short-term risk, SEYE is less volatile compared to REMI. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check REMI's competition here
SEYE vs SDCCQ Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SDCCQ has a market cap of 13.4K. Regarding current trading prices, SEYE is priced at $0.00, while SDCCQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SDCCQ's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to SDCCQ's ROE of -0.61%. Regarding short-term risk, SEYE and SDCCQ have similar daily volatility (0.00).Check SDCCQ's competition here
SEYE vs MDIT Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, MDIT has a market cap of 8.7K. Regarding current trading prices, SEYE is priced at $0.00, while MDIT trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas MDIT's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to MDIT's ROE of -0.99%. Regarding short-term risk, SEYE and MDIT have similar daily volatility (0.00).Check MDIT's competition here
SEYE vs ASFX Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ASFX has a market cap of 7K. Regarding current trading prices, SEYE is priced at $0.00, while ASFX trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ASFX's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to ASFX's ROE of +0.00%. Regarding short-term risk, SEYE is less volatile compared to ASFX. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check ASFX's competition here
SEYE vs DGEN Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, DGEN has a market cap of 3.9K. Regarding current trading prices, SEYE is priced at $0.00, while DGEN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas DGEN's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to DGEN's ROE of +0.05%. Regarding short-term risk, SEYE and DGEN have similar daily volatility (0.00).Check DGEN's competition here
SEYE vs SVSO Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SVSO has a market cap of 2.6K. Regarding current trading prices, SEYE is priced at $0.00, while SVSO trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SVSO's P/E ratio is -0.01. In terms of profitability, SEYE's ROE is N/A, compared to SVSO's ROE of +0.17%. Regarding short-term risk, SEYE and SVSO have similar daily volatility (0.00).Check SVSO's competition here
SEYE vs LFPI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, LFPI has a market cap of 2.1K. Regarding current trading prices, SEYE is priced at $0.00, while LFPI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas LFPI's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to LFPI's ROE of -4.85%. Regarding short-term risk, SEYE is less volatile compared to LFPI. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check LFPI's competition here
SEYE vs INND Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, INND has a market cap of 1.2K. Regarding current trading prices, SEYE is priced at $0.00, while INND trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas INND's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to INND's ROE of +0.09%. Regarding short-term risk, SEYE and INND have similar daily volatility (0.00).Check INND's competition here
SEYE vs BGMD Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, BGMD has a market cap of 1.1K. Regarding current trading prices, SEYE is priced at $0.00, while BGMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas BGMD's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to BGMD's ROE of +7.47%. Regarding short-term risk, SEYE and BGMD have similar daily volatility (0.00).Check BGMD's competition here
SEYE vs ADLI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, ADLI has a market cap of 1K. Regarding current trading prices, SEYE is priced at $0.00, while ADLI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas ADLI's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to ADLI's ROE of +1.36%. Regarding short-term risk, SEYE is less volatile compared to ADLI. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check ADLI's competition here
SEYE vs VSMD Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, VSMD has a market cap of 802. Regarding current trading prices, SEYE is priced at $0.00, while VSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas VSMD's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to VSMD's ROE of +3.15%. Regarding short-term risk, SEYE is less volatile compared to VSMD. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check VSMD's competition here
SEYE vs TEVNF Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, TEVNF has a market cap of 744. Regarding current trading prices, SEYE is priced at $0.00, while TEVNF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas TEVNF's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to TEVNF's ROE of +3.22%. Regarding short-term risk, SEYE is less volatile compared to TEVNF. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check TEVNF's competition here
SEYE vs HRAL Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, HRAL has a market cap of 396. Regarding current trading prices, SEYE is priced at $0.00, while HRAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas HRAL's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to HRAL's ROE of +0.21%. Regarding short-term risk, SEYE is less volatile compared to HRAL. This indicates potentially lower risk in terms of short-term price fluctuations for SEYE.Check HRAL's competition here
SEYE vs MICRD Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, MICRD has a market cap of 317. Regarding current trading prices, SEYE is priced at $0.00, while MICRD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas MICRD's P/E ratio is -0.00. In terms of profitability, SEYE's ROE is N/A, compared to MICRD's ROE of -0.25%. Regarding short-term risk, SEYE and MICRD have similar daily volatility (0.00).Check MICRD's competition here
SEYE vs RGBOQ Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, RGBOQ has a market cap of 97. Regarding current trading prices, SEYE is priced at $0.00, while RGBOQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas RGBOQ's P/E ratio is -0.00. In terms of profitability, SEYE's ROE is N/A, compared to RGBOQ's ROE of N/A. Regarding short-term risk, SEYE and RGBOQ have similar daily volatility (0.00).Check RGBOQ's competition here
SEYE vs SECI Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, SECI has a market cap of 31. Regarding current trading prices, SEYE is priced at $0.00, while SECI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas SECI's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to SECI's ROE of -0.00%. Regarding short-term risk, SEYE and SECI have similar daily volatility (0.00).Check SECI's competition here
SEYE vs VTEQ Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, VTEQ has a market cap of 1. Regarding current trading prices, SEYE is priced at $0.00, while VTEQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas VTEQ's P/E ratio is -0.00. In terms of profitability, SEYE's ROE is N/A, compared to VTEQ's ROE of N/A. Regarding short-term risk, SEYE and VTEQ have similar daily volatility (0.00).Check VTEQ's competition here
SEYE vs OCPNY Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, OCPNY has a market cap of 0. Regarding current trading prices, SEYE is priced at $0.00, while OCPNY trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas OCPNY's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to OCPNY's ROE of +0.26%. Regarding short-term risk, SEYE and OCPNY have similar daily volatility (0.00).Check OCPNY's competition here
SEYE vs MEDVD Comparison April 2026
SEYE plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, SEYE stands at 1.2K. In comparison, MEDVD has a market cap of 0. Regarding current trading prices, SEYE is priced at $0.00, while MEDVD trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
SEYE currently has a P/E ratio of N/A, whereas MEDVD's P/E ratio is N/A. In terms of profitability, SEYE's ROE is N/A, compared to MEDVD's ROE of N/A. Regarding short-term risk, SEYE and MEDVD have similar daily volatility (0.00).Check MEDVD's competition here